bg medicine inc (BGMD:NASDAQ GM)

Executive Profile*

Background*

Dr. Jan van der Greef is the Co-Founder and Scientific Advisor of RDAB Board of BG Medicine Inc. Dr. van der Greef is a Co-Founder of Beyond Genomics Inc, the Center for Medical Systems Biology, and Kiadis. He was an Operational Partner at Gilde Healthcare Partners B.V. He has served as the Chief Executive Officer and Scientific Director of Systems Biology Research at TNO Pharma for 15 years. Dr. van der Greef is a Member of the Scientific Advisory Board of Biotech and ... Nutrition Fund at Gilde Investment Management. He was also a Member of Industrial Advisory Board at Sarsia Life Science Fund AS. Dr. van der Greef is a Professor of Analytical Chemistry and Analytical BioSciences at Leiden University (NL) within the Leiden/Amsterdam Center for Drug Research. He has published over 250 papers in international journals and supervised more than 22 PhD thesis projects. Dr. van der Greef received an award for major contributions in drug analysis by the Belgium Society of Pharmaceutical Sciences in 1998 and received the AAPS Pharmaceutical Scientist award as one of the authors of the best analytical paper in 2002. His current research interest includes the development of systems biology with novel proteomics technologies, metabolomics fingerprinting and biostatistics, applied to the characterization of complex biological systems. Dr. van der Greef is considered a pioneer in the field of liquid chromatography coupled to mass spectrometry (LCMS), bodyfluid profiling and pattern recognition, and among the first to develop single cell profiling by mass spectrometry. He became Honorary Doctor at Ghent University in 2000.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
BGMD:US	$1.57 USD	-0.06

COMPETITOR COMPENSATION